Open AccessAn evaluation of knowledge, attitude, and practice of institutional ethics committee members from eastern India regarding ethics committee functioning and pharmacovigilance activities conducted during clinical trials: A pilot study
Author(s) -
Subhrojyoti Bhowmick,
K. Banerjee,
Shreya Sikdar,
Tapan K. Chatterjee
Publication year - 2014
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.134310
Subject(s) - pharmacovigilance , medicine , family medicine , ethics committee , clinical trial , government (linguistics) , alternative medicine , test (biology) , research ethics , medical education , adverse effect , pharmacology , political science , pathology , psychiatry , paleontology , linguistics , philosophy , public administration , biology
The vital responsibility of Institutional Ethics Committee (IEC) members is to ensure the safety of the subjects participating in clinical trials. Hence, it is essential for IEC members to be aware of the common pharmacovigilance strategies followed during clinical trials. However, the information about the knowledge, attitude, and practice of IEC members regarding the pharmacovigilance activities followed during clinical trials is scarce worldwide, especially in India. Hence, this cross-sectional study was designed to assess the knowledge, attitude, and practice of IEC members of 10 hospitals of Kolkata, India.